Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Acker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chemical Reviews|October 3, 2014
Current and potential treatments for ubiquitous but neglected herpesvirus infectionsJonathan E Gable, Timothy M Acker, Charles S Craik
Journal of Medicinal Chemistry|August 6, 2013
Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonistsTimothy M Acker, Alpa Khatri, Katie M Vance, et al.
Expert Opinion on Therapeutic Patents|September 27, 2012
Novel NMDA receptor modulators: an updateRose M Santangelo, Timothy M Acker, Sommer S Zimmerman, et al.
Molecular Cancer Therapeutics|July 23, 2008
The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosisShruti M Raja, Shuzhen Chen, Ping Yue, et al.
Journal of the American Chemical Society|August 1, 2017
Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus ProteasesTimothy M Acker, Jonathan E Gable, Markus-Frederik Bohn, et al.
Chemmedchem|January 30, 2016
Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric ProteaseJonathan E Gable, Gregory M Lee, Timothy M Acker, et al.
Journal of Medicinal Chemistry|August 6, 2010
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonistsCara A Mosley, Timothy M Acker, Kasper B Hansen, et al.
Molecular Pharmacology|August 3, 2011
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulatorsTimothy M Acker, Hongjie Yuan, Kasper B Hansen, et al.
Journal of Pharmaceutical Sciences|June 21, 2024
Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal AntibodiesMark A Bryniarski, Md Tariqul Haque Tuhin, Timothy M Acker, et al.
The Journal of Biological Chemistry|February 1, 2022
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACsNan Bai, Kristin M Riching, Aman Makaju, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chemical Reviews|October 3, 2014
Current and potential treatments for ubiquitous but neglected herpesvirus infectionsJonathan E Gable, Timothy M Acker, Charles S Craik
Journal of Medicinal Chemistry|August 6, 2013
Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonistsTimothy M Acker, Alpa Khatri, Katie M Vance, et al.
Expert Opinion on Therapeutic Patents|September 27, 2012
Novel NMDA receptor modulators: an updateRose M Santangelo, Timothy M Acker, Sommer S Zimmerman, et al.
Molecular Cancer Therapeutics|July 23, 2008
The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosisShruti M Raja, Shuzhen Chen, Ping Yue, et al.
Journal of the American Chemical Society|August 1, 2017
Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus ProteasesTimothy M Acker, Jonathan E Gable, Markus-Frederik Bohn, et al.
Chemmedchem|January 30, 2016
Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric ProteaseJonathan E Gable, Gregory M Lee, Timothy M Acker, et al.
Journal of Medicinal Chemistry|August 6, 2010
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonistsCara A Mosley, Timothy M Acker, Kasper B Hansen, et al.
Molecular Pharmacology|August 3, 2011
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulatorsTimothy M Acker, Hongjie Yuan, Kasper B Hansen, et al.
Journal of Pharmaceutical Sciences|June 21, 2024
Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal AntibodiesMark A Bryniarski, Md Tariqul Haque Tuhin, Timothy M Acker, et al.
The Journal of Biological Chemistry|February 1, 2022
Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACsNan Bai, Kristin M Riching, Aman Makaju, et al.
Pageof 2